TZ3O

CAS No. 2218754-19-7

TZ3O( —— )

Catalog No. M37043 CAS No. 2218754-19-7

TZ3O is an anticholinergic compound with neuroprotective activity.TZ3O ameliorates memory impairment and cognitive decay in Scopolamine-induced Alzheimer's type model in rats, and can be used in the study of Alzheimer's disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 321 In Stock
10MG 459 In Stock
25MG 718 In Stock
50MG 958 In Stock
100MG 1274 In Stock
200MG 1721 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TZ3O
  • Note
    Research use only, not for human use.
  • Brief Description
    TZ3O is an anticholinergic compound with neuroprotective activity.TZ3O ameliorates memory impairment and cognitive decay in Scopolamine-induced Alzheimer's type model in rats, and can be used in the study of Alzheimer's disease.
  • Description
    TZ3O is an anticholinergic compound with neuroprotective activity.TZ3O ameliorates memory impairment and cognitive decay in Scopolamine-induced Alzheimer's type model in rats, and can be used in the study of Alzheimer's disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    AChR
  • Recptor
    AChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2218754-19-7
  • Formula Weight
    339.37
  • Molecular Formula
    C18H13NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1SC(=CC=2C=CC=C(O)C2)C(=O)N1CC(=O)C=3C=CC=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • tiquizium

    Tiquizium has effective Antimuscarinic effect, and causes significant bronchodilation in patients with chronic obstructive pulmonary disease.

  • TC-T 6000

    TC-T 6000 (hENT4-IN-1) is a selective and potent inhibitor of human equilibrium nucleoside transporter protein 4 (ENT4) (IC50: 74.4 nM) with vasodilator activity, inhibits hENT1 and hENT2, and can be used for the study of cancer and cardiovascular injury.

  • VU0152099

    VU0152099 is a potent and selective M4 mAChR allosteric potentiator(EC50 = 380 ± 93 nM).